Psilocybin trials for substance use (any)
17 recruiting now and 5 not yet recruiting, grouped by the conditions each study lists on ClinicalTrials.gov, read 28 October 2026. Recruiting trials are listed first.
- RecruitingPhase 1NCT04161066
Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine
Opioid Use Disorder · University of Wisconsin, Madison · Ages 21 to 65
Madison, Wisconsin, United States
- RecruitingPhase 2NCT05452772
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Tobacco Use Disorder · Johns Hopkins University · Ages 21+
3 sites in United States (Birmingham, Baltimore, New York)
- RecruitingPhase 2NCT05585229
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication
Opioid Dependence, Chronic Pain · University of British Columbia · Ages 19 to 75
Kelowna, British Columbia, Canada
- RecruitingPhase 2NCT05995769
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
Alcohol Use Disorder, Alcoholism · University of Calgary · Ages 22 to 65
Calgary, Alberta, Canada
- RecruitingPhase 2NCT06067737
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
Opioid Use Disorder · Johns Hopkins University · Ages 21 to 70
Baltimore, Maryland, United States
- RecruitingPhase 1NCT06160284
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
Opioid Use Disorder · Yale University · Ages 25 to 55
New Haven, Connecticut, United States
- RecruitingPhase 2NCT06349083
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD
Alcohol Use Disorder · NYU Langone Health · Ages 18 to 65
New York, New York, United States
- RecruitingPhase 2NCT06405607
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Alcohol Use Disorder, Alcohol Dependence, Alcohol Abuse · University of Iowa · Ages 21 to 65
Iowa City, Iowa, United States
- RecruitingPhase 1NCT06442423
Open-Label Psilocybin Study in Transdiagnostic Population
Transdiagnostic, Depression - Major Depressive Disorder, Anxiety · Yale University · Ages 18+
New Haven, Connecticut, United States
- RecruitingPhase 1NCT06660381
Psilocybin-assisted Treatment for Cannabis Use Disorder
Cannabis Use Disorder · Johns Hopkins University · Ages 18+
Baltimore, Maryland, United States
- RecruitingPhase 2NCT06786325
Wellcome Leap Psilocybin for OUD
Opioid Use Disorder · Anna Rose Childress, Ph.D. · Ages 18 to 60
Philadelphia, Pennsylvania, United States
- RecruitingPhase 2NCT06796062
Psilocybin for Opioid Use Disorder (OUD)
Opioid Use Disorder · NYU Langone Health · Ages 18 to 65
5 sites in United States
- RecruitingPhase 2NCT06810310
Psilocybin on Brain Mechanisms of Motivation in OUD
Opioid Use Disorder · University of Pennsylvania · Ages 18 to 60
Philadelphia, Pennsylvania, United States
- RecruitingEarly phase 1NCT06899594
Psilocybin for Methamphetamine Addiction
Methamphetamine Use Disorder · Kevin Murnane · Ages 25 to 65
Shreveport, Louisiana, United States
- RecruitingEarly phase 1NCT07118332
Psilocybin as a Treatment for Chronic Pain in Smokers
Smokers With Chronic Pain · Yale University · Ages 21 to 65
2 sites in United States (West Haven)
- RecruitingPhase 2NCT07405606
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD) · Centre for Addiction and Mental Health · Ages 18 to 65
Toronto, Ontario, Canada
- RecruitingPhase 3NCT07638553
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
Alcohol Use Disorder, Depressive Sympotoms, Psilocybin · Centre Hospitalier Universitaire de Nīmes · Ages 18+
8 sites in France
- Not yet recruitingPhase 2NCT07296094
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
Alcohol Use Disorder · Brigham and Women's Hospital · Ages 18 to 65
Boston, Massachusetts, United States
- Not yet recruitingPhase 1 / Phase 2NCT07499583
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
Treatment Resistant Depression, Substance Use Disorders · Indiana University · Ages 18+
2 sites in United States (Indianapolis)
- Not yet recruitingPhase 2NCT07756736
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV) · Nicky Mehtani, MD, MPH · Ages 25 to 64
San Francisco, California, United States
- Not yet recruitingPhase 2NCT07774702
Psilocybin for Methamphetamine Use Disorder
Methamphetamine Use Disorder · Peter Hendricks · Ages 18+
Birmingham, Alabama, United States
- Not yet recruitingPhase 2NCT07852832
Effects of Psilocybin on Craving in Nicotine Dependence
Nicotine Dependence · University of British Columbia · Ages 20 to 35
Sites not yet listed
How joining a trial works
- Free to take part
- Trials generally cost participants nothing for the study drug and the study visits, and some pay for travel or time. Check what a study covers on its registry page.
- Screened first
- Every study screens volunteers with questionnaires, medical history and often a physical and psychiatric check. Many people who apply are not enrolled.
- Eligibility is strict
- Common exclusions include a personal or family history of psychosis or bipolar disorder, some heart conditions, pregnancy and certain medications, which you may be asked to stop under medical supervision. Never stop a medication on your own to qualify.
- You may get a placebo
- Many trials compare psilocybin with a placebo or a low dose, and you may not be told which you had until the study ends.
- Contact the study team through the registry
- Each registry record lists the study contacts and sites. We do not republish personal emails or phone numbers; use the link on each trial page.
- Not medical advice
- This is a list of registry records, not a recommendation. Talk to your doctor before applying. Disclaimer · Safety and medications
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine, read 28 October 2026. Filter: overall status RECRUITING or NOT_YET_RECRUITING; an intervention named psilocybin, psilocin, COMP360 or CYB003. Refreshed weekly; a study's own registry page is always the current record.